| HOME >> MEDICINE >> TECHNOLOGY |
Figure 51: CNS Disorder Therapeutic Market, Insomnia, Annual Cost of Treatment ($), 2002-2017 84
Figure 52: CNS Disorder Therapeutic Market, Insomnia, Global Treatment Usage Patterns (Thousand), 2002-2017 85
Figure 53: CNS Disorder Therapeutic Market, Insomnia, Global Market Drivers and Barriers, 2010-2017 87
Figure 54: CNS Disorder Therapeutic Market, Migraine, Treatment Algorithm 89
Figure 55: CNS Disorder Therapeutic Market, Migraine, Global Revenue Forecast ($m), 2002-2017 90
Figure 56: CNS Disorder Therapeutic Market, Migraine, Revenue by Country ($m), 2002-2017 91
Figure 57: CNS Disorder Therapeutic Market, Migraine, Generic Share in Migraine Market, 2010 and 2017 93
Figure 58: CNS Disorder Therapeutic Market, Migraine, Annual Cost of Treatment ($), 2002-2017 94
Figure 59: CNS Disorder Therapeutic Market, Migraine, Global Treatment Usage Patterns (Thousand), 2002-2017 95
Figure 60: CNS Disorder Therapeutic Market, Migraine, Global Market Drivers and Barriers, 2010-2017 98
Figure 61: CNS Disorder Therapeutic Market, Multiple Sclerosis (RRMS), Treatment Algorithm 101
Figure 62: CNS Disorder Therapeutic Market, Multiple Sclerosis (PRMS), Treatment Algorithm 102
Figure 63: CNS Disorder Therapeutic Market, Multiple Sclerosis, Global Revenue Forecast ($m), 2002-217 103
Figure 64: CNS Disorder Therapeutic Market, Multiple Sclerosis, Revenue by Country ($m), 2002-2017 104
Figure 65: CNS Disorder Therapeutic Market, Multiple Sclerosis, Generic Share in Multiple Sclerosis Market, 2010 and 2017 105
Figure 66: CNS Disorder Therapeutic Market, Multiple Sclerosis, Annual Cost of Treatment ($), 2002-2017 106
Figure 67: CNS Disorder Therapeutic Market, Multiple Sclerosis, Global Treatment Usage Pattern (Thousand), 2002-2017 107
Figure 68: CNS Disorder Therapeutic Market, Multiple Sclerosis, Global Market Drivers and Restraints, 2010-2017 109
Fig
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |